Anzeige
Meldung des Tages: Prospect Markets tritt Google Cloud Programm bei: Meilenstein für Echtzeit-Sportprognosen

Karyopharm Therap. News

Aktie
WKN:  A40YLC ISIN:  US48576U2050 US-Symbol:  KPTI Branche:  Biotechnologie Land:  USA
4,52 €
-0,14 €
-3,00%
12:43:17 Uhr
Depot/Watchlist
Marktkapitalisierung *
3,52 Mio. €
Streubesitz
60,73%
KGV
-0,61
Index-Zuordnung
-

Karyopharm Therapeutics News

01.08.25 - PR Newswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
01.07.25 - PR Newswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
03.06.25 - PR Newswire
Karyopharm to Present at the Jefferies Global Healthcare Conference
Karyopharm to Present at the Jefferies Global Healthcare Conference PR Newswire
02.06.25 - PR Newswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
19.05.25 - PR Newswire
Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference
Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference PR Newswire
14.05.25 - PR Newswire
Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting
Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting PR Newswire
12.05.25 - PR Newswire
Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hemoglobin Stabilization and Disease Modification
Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume ...
08.05.25 - PR Newswire
Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025
Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025 PR Newswire
01.05.25 - PR Newswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
01.04.25 - PR Newswire
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Newssuche

Videos

newspaper
30.03.26 +2,91%
Technical Trading 73% Trefferquote
GBP/USD Long Typ: Turbo Open End WKN: VG541T Hebel:30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »